Literature DB >> 12163231

The other side of TGF-beta superfamily signal regulation: thinking outside the cell.

Tina L Gumienny1, Richard W Padgett.   

Abstract

The transforming growth factor beta (TGF-beta) superfamily of paracrine and autocrine signaling molecules regulates a vast array of developmental and homeostatic processes and is itself exquisitely regulated. The misregulation of these molecules often results in cancer and other diseases. Here, we focus on new research that explores how TGF-beta superfamily signaling is controlled between the secreting cell and the target cell. Regulation can occur upon ligand secretion (in a latent protein complex) and in the creation of signaling gradients. Proteins in the extracellular milieu sequester ligand away from or facilitate ligand binding to receptor serine kinases. Ligands even positively regulate their own negative regulators. Studies of how TGF-beta signaling is regulated extracellularly have broadened our understanding of TGF-beta pathways, and could provide clues to our understanding and treatment of diseases resulting from misregulation of these pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163231     DOI: 10.1016/s1043-2760(02)00615-x

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  12 in total

1.  E-selectin ligand-1 regulates growth plate homeostasis in mice by inhibiting the intracellular processing and secretion of mature TGF-beta.

Authors:  Tao Yang; Roberto Mendoza-Londono; Huifang Lu; Jianning Tao; Kaiyi Li; Bettina Keller; Ming Ming Jiang; Rina Shah; Yuqing Chen; Terry K Bertin; Feyza Engin; Branka Dabovic; Daniel B Rifkin; John Hicks; Milan Jamrich; Arthur L Beaudet; Brendan Lee
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia.

Authors:  Jingmei Lin; Sanjeevkumar R Patel; Min Wang; Gregory R Dressler
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  Kielin/chordin-like protein attenuates both acute and chronic renal injury.

Authors:  Abdul Soofi; Peng Zhang; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

4.  Caenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling.

Authors:  Tina L Gumienny; Lesley Macneil; Cole M Zimmerman; Huang Wang; Lena Chin; Jeffrey L Wrana; Richard W Padgett
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

5.  Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.

Authors:  Robert Matthew Kottmann; Ajit A Kulkarni; Katie A Smolnycki; Elizabeth Lyda; Thinesh Dahanayake; Rami Salibi; Sylvie Honnons; Carolyn Jones; Nancy G Isern; Jian Z Hu; Steven D Nathan; Geraldine Grant; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Crit Care Med       Date:  2012-08-23       Impact factor: 21.405

6.  The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice.

Authors:  Abdul Soofi; Katherine I Wolf; Egon J Ranghini; Mohammad A Amin; Gregory R Dressler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

7.  Glycosylation of Twisted Gastrulation is Required for BMP Binding and Activity during Craniofacial Development.

Authors:  Charles J Billington; Juliane E Fiebig; Cynthia L Forsman; Lan Pham; Nathan Burbach; Mu Sun; Tina Jaskoll; Kim Mansky; Rajaram Gopalakrishnan; Michael B O'Connor; Thomas D Mueller; Anna Petryk
Journal:  Front Physiol       Date:  2011-09-12       Impact factor: 4.566

8.  Heparin-mediated dimerization of follistatin.

Authors:  Ryan G Walker; Chandramohan Kattamuri; Erich J Goebel; Fuming Zhang; Michal Hammel; John A Tainer; Robert J Linhardt; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-16

Review 9.  Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

Authors:  Divya Thomas; Ashok Kumar Rathinavel; Prakash Radhakrishnan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-11-04       Impact factor: 10.680

10.  The neuroprotective functions of transforming growth factor beta proteins.

Authors:  Arpád Dobolyi; Csilla Vincze; Gabriella Pál; Gábor Lovas
Journal:  Int J Mol Sci       Date:  2012-07-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.